Delivery Order SPE2DB20D3103-SPE2DB25FM2M3

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565532789 - CLOBAZAM 10 MG TABLET 100S. The award has a firm fixed price of $6,296.78 and an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CLOBAZAM 10 MG TABLET 100S. The contract has a ceiling value of $6,325.69 and a period of performance through December 12, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,136.91, is for the delivery of 4566304062 - CLOBAZAM 10 MG TABLET 100S. The contract is a firm fixed-price delivery order with a period of performance through November 4, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,856.52 firm fixed-price delivery order is for the supply of 4566748542 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,302.58 firm fixed-price delivery order is for the supply of 4566848238 - CLOBAZAM 10 MG TABLET 100S, with a completion date of January 7, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAM77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a medication, and has a ceiling value of $2,002.00. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance runs through December 30, 2024. This contract appears to be...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,779.65, is for the delivery of 4566422120 CLOBAZAM 10 MG TABLETs. It is a firm fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565166084 CLOBAZAM 10 MG TABLET 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $5,157.36 firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,296.60, is for the delivery of 4,566,848 units of the drug Clobazam 10 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2M3
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,727.79 and is for the delivery of 4566872730 CLOBAZAM 10 MG TABLET 100S. The contract is a Firm Fixed Price arrangement with a period of performance through January 9, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:58 AM